The Why, Where, Who, How, and What of the vesicular delivery systems

B Kapoor, R Gupta, M Gulati, SK Singh… - Advances in colloid and …, 2019 - Elsevier
Though vesicular delivery systems have been widely explored and reviewed, no
comprehensive review exists that covers their development from the inception of the concept …

Delivery strategies and potential targets for siRNA in major cancer types

SJ Lee, MJ Kim, IC Kwon, TM Roberts - Advanced drug delivery reviews, 2016 - Elsevier
Small interfering RNA (siRNA) has gained attention as a potential therapeutic reagent due to
its ability to inhibit specific genes in many genetic diseases. For many years, studies of …

Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy

S Shakil, MH Baig, S Tabrez, SMD Rizvi… - Seminars in Cancer …, 2019 - Elsevier
Cancer is a disease that has been the focus of scientific research and discovery and
continues to remain so. Polo-like kinases (PLKs) are basically serine/threonine kinase …

[Retracted] miR‐451a Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer via Macrophage Migration Inhibitory Factor

Z Liu, T Miao, T Feng, Z Jiang, M Li… - BioMed research …, 2015 - Wiley Online Library
This study aims to investigate the regulative effects of microRNA‐451a (miR‐451a) on cell
proliferation and sensitivity to tamoxifen in breast cancer cells. In cell culture experiments …

Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches

L Zhang, Y Huang, J Ling, W Zhuo, Z Yu… - Cancer …, 2018 - content.iospress.com
BACKGROUND: Liver carcinoma is a major cause of cancer-related death worldwide. Up to
date, the mechanisms of liver cancerigenesis and development have not been fully …

Immunotherapy for bone and soft tissue sarcomas

T Uehara, T Fujiwara, K Takeda… - BioMed research …, 2015 - Wiley Online Library
Although multimodal therapies including surgery, chemotherapy, and radiotherapy have
improved clinical outcomes of patients with bone and soft tissue sarcomas, the prognosis of …

Dendrimer-PLGA based multifunctional immuno-nanocomposite mediated synchronous and tumor selective delivery of siRNA and cisplatin: potential in treatment of …

MA Sherwani, S Tufail, AA Khan, M Owais - RSC Advances, 2015 - pubs.rsc.org
Considering the subdued efficacy of a single therapeutic modality in successful treatment of
cancer, co-operative inhibition of cancer progression employing a combination of two or …

Potential of siRNA-bearing subtilosomes in the treatment of diethylnitrosamine-induced hepatocellular carcinoma

F Jamal, G Ahmed, M Farazuddin, I Altaf, S Farheen… - Molecules, 2023 - mdpi.com
Therapeutics, based on small interfering RNA (siRNA), have demonstrated tremendous
potential for treating cancer. However, issues such as non-specific targeting, premature …

RNA interference as a therapeutic strategy for the treatment of liver diseases

A Gonzalez-Rodriguez… - Current Pharmaceutical …, 2015 - ingentaconnect.com
RNA interference has emerged as an innovative technology for gene silencing that
degrades mRNAs complementary to the antisense strands of double-stranded, short …

Nano-sized drug delivery systems: development and implication in treatment of hepatocellular carcinoma

KF Badrealam, M Owais - Digestive Diseases, 2015 - karger.com
Liver cancer results in enormous human toll worldwide. Over the years, various
chemotherapeutic entities have been employed for treatment of advanced HCC; however …